Jazz Pharmaceuticals buys Epidiolex manufacturer GW Pharma for $7.2bn

GW Pharmaceuticals, the British manufacturer of the CBD-based epilepsy drug Epidiolex, has been acquired by Jazz Pharmaceuticals in a cash and shares deal worth over $7bn ...

Restricted content. Do you want to read more?